[S44] Harmonization of pharmaceutical regulation and medical innovation: Those who master regulation, achieve medical innovation

[S44-04] Development of in vitro intestinal model using human iPS cells- and human biopsy-derived intestinal organoids.

○Hiroyuki Mizuguchi^1,2,3,4,5 (1. Graduate School of Pharmaceutical Sciences, Osaka University, 2. National Institutes of Biomedical Innovation, Health and Nutrition, 3. Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 4. Global Center for Medical Engineering and Informatics, Osaka University, 5. Center for Infectious Disease Education and Research (CiDER), Osaka University)